Frequently Asked Questions
The market is segmented based on Segmentation, By Technology (Internal Neuromodulation, External Neuromodulation), Application (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation, Respiratory Electrical Stimulation), Biomaterial (Ceramics Biomaterials, Metallic Biomaterials, Polymeric Biomaterials), End-User (Hospitals, Clinics, Home Healthcare) – Industry Trends and Forecast to 2031.
.
The Global Neuromodulation Market size was valued at USD 8.06 USD Billion in 2023.
The Global Neuromodulation Market is projected to grow at a CAGR of 11.6% during the forecast period of 2024 to 2031.
The major players operating in the market include Medtronic, Boston Scientific Corporation, NEVRO CORP, Cyberonics , Inspire Medical Systems , SPR Therapeutics, ALEVA NEUROTHERAPEUTICS SA, Bioness , ReShape Lifesciences , LivaNova PLC, NeuroPace , Synapse Biomedical , Soterix Medical , Accellent Technologies , Abbott, Bioventus, Integer Holdings Corporation, NeuroSigma , Neuronetics, BioControl Medical,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
